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TO THE EDITOR
While skin color is the most notable
difference among ethnic skins, many
other differences exist in the structure
and function of ethnic skins. Unfortu-
nately, the current knowledge of phy-
siological and pathological properties
of the skin is based mainly on Cauca-
sian skin studies (reviewed in Taylor,
2002). Elucidating differences among
ethnic skins is not only of great biolo-
gical importance, but also of great
interest in skin care improvement.
Keratinocytes play an important role
in skin physiology, affecting skin barrier
function, immune responses and
wound-healing processes (Williams
and Kupper, 1996). Earlier studies
documented the role of the keratinocyte
receptor PAR-2 in the regulation of skin
pigmentation (Seiberg et al., 2000a, b;
Paine et al., 2001), and the differential
expression of the PAR-2 pathway in
keratinocytes of different ethnic origins
(Babiarz-Magee et al., 2004). In order
to identify other differences in kerati-
nocytes’ expression profiles, we per-
formed DNA chip analysis of
keratinocytes obtained from different
skin types (four individuals of either
lightly (LK) or darkly (DK) pigmented
skins) (Cascade Biologics, Portland,
OR). When evaluating expression levels
of cathepsins (chip results, Table S1),
only cathepsin L2 (CTSL2) was found to
be differentially expressed in relation to
pigmentary skin backgrounds, and was
about 7.5-folds higher in keratinocytes
from lightly pigmented, relative to
darkly pigmented skins (Table S1).
CTSL2 is a lysosomal cysteine protease
(Adachi et al., 1998; Santamaria et al.,
1998; Bromme et al., 1999). It is
expressed in primary keratinocytes,
melanocytes, and HaCaT keratinocytes
(Figure 1a), but not in primary fibro-
blasts (Figure 1b). The differential ex-
pression of CTSL2 mRNA in
keratinocytes (but not of other cathe-
psins and of cystatins, the natural
inhibitors of cathepsins) was confirmed
by reverse transcriptase (RT)-PCR
(Figure 1c; Table S2 in Supplementary
material for primers). Interestingly,
melanocytes from different ethnic
origins expressed the same levels of
CTSL2 mRNA (Figure 1d).
Western blot analysis of keratino-
cytes using polyclonal antibodies
specific to CTSL2 (Figure S1) showed
that keratinocytes derived from lightly
pigmented skins (LK) have about
3.5-fold increase in CTSL2 protein
levels (normalized by b-actin) relative
to those of darkly pigmented skins (DK)
(Figure 2a). In addition, CTSL2 protein
levels in human skins with different
levels of pigment deposition (as shown
by Fontana–Mason staining, Figure 2b
and c) were analyzed by immunohisto-
chemistry staining. In agreement
with the CTSL2 mRNA levels in ethnic
skins, CTSL2 protein levels were
found to be higher in lighter skins, and
strongly reduced in darker skins
(Figure 2d and e).
To date, there are no specific in-
hibitors to CTSL2; therefore, we could
not directly measure CTSL2 activity in
keratinocyte’s derived from skins of
different colors. The total enzymatic
activity of cathepsins was measured
using substrate Z-Phe-Arg-AMC
(Bachem, Torrance, CA). Substrate
hydrolysis catalyzed by cathepsins
was monitored by fluorescent emission
(excitation at 360 nm and emission at
465 nm). Cell lysate of keratinocytes
from lightly pigmented skins showed
1.570.16-fold higher cathepsin activity
than keratinocytes derived from darker
skins (data were pooled from threeAbbreviations: CTSL2, cathepsin L2; RT, reverse transcriptase
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independent experiments). CA074, a
specific cathepsin B inhibitor, reduced
keratinocytes cathepsin B activity by
B70%. Cathepsin activities of CA074-
treated keratinocytes were about 2.2-
fold higher in light-skin-derived kerati-
nocytes versus dark ones (for Materials
and Methods, see Supplementary mate-
rials). Since overall cathepsin expression
(excluding CSTL2) is similar in both
dark and light keratinocytes (Table S1
and Figure 1), the difference of the
remaining cathepsin activity represents
CTSL2. This suggests that the total
CTSL2 enzymatic activity is higher in
light-skin-derived keratinocytes.
Cathepsins are a large family of
lysosomal cysteine proteases, which
are involved in numerous cellular
processes. CTSL2 shares 80% protein
sequence identity with CTSL, but its
expression is mostly confined to the
thymus, testis, and cornea (Adachi
et al., 1998; Santamaria et al., 1998;
Bromme et al., 1999). In skin, CTSL2
was isolated from human stratum cor-
neum (Watkinson, 1999; Bernard et al.,
2003) and was shown to have a high
caseinolytic activity, which is distinct
from that of CTSL. To date, no CTSL2
ortholog has been identified in mice,
and the human CTSL2 protein is more
homologous to the mouse CTSL than to
the human CTSL sequence (Bromme
et al., 1999). ctsl/ mice exhibit a
complex skin phenotype consisting of
periodic hair loss and epidermal hyper-
plasia with hyperproliferation of basal
epidermal keratinocytes, acanthosis,
and hyperkeratosis, but no appreciable
changes in hair pigmentation (Roth
et al., 2000; Benavides et al., 2002;
Tobin et al., 2002). This defective skin
and hair phenotype was largely rescued
by human keratin 14 promoter driven
CTSL2 (Hagemann et al., 2004). These
data suggest that the CTSL2 proteolytic
activities play a role in the maintenance
of homeostasis of both the epidermis
and the hair follicles. While the differ-
ential expression of CTSL2 was discov-
ered in relation to skin color, we could
not find evidence for the differential
expression of CTSL2 in melanocytes, or
for the regulation of melanogenesis via
CTSL2. Our data demonstrate ethnic
skin differences that are not directly
associated with melanogenesis, ex-
panding on ethnic skin differences































Figure 1. CTSL2 mRNA expression is higher in
keratinocytes from lighter-colored skins. (a) RNA
was isolated from primary neonatal keratinocytes
(K), melanocytes (M), and from HaCaT cells (H).
CTSL2 expression was analyzed by RT-PCR.
(b) RNA was isolated from primary fibroblasts
and analyzed by RT-PCR for CTSL2, CTSL, and
CTSB expression. (c) Neonatal keratinocytes from
lightly and darkly pigmented skins (LK and DK,
respectively) were analyzed by RT-PCR for
expression levels of CTSL, CTSB, CTSL2,
and cystatins A, B, and C (the endogenous
physiological inhibitors of cathepsins). Only
CTSL2 was differentially expressed in
keratinocytes of different skin colors. The
experiment was repeated three times with
different lots of keratinocytes. Representative data
are shown. (d) Neonatal melanocytes from lightly
and darkly pigmented skins (LM and DM,
respectively) were analyzed by RT-PCR for
expression levels of CTSL, CTSB, and CTSL2. No
differential expression was identified in
melanocytes of different skin colors. The
experiment was repeated three times with
different lots of melanocytes. Representative data








Figure 2. CTSL2 protein levels inversely correlate with skin color. (a) Keratinocytes obtained from lightly
pigmented skin (LK) have higher levels of CTSL2 protein than those of darkly pigmented skins (DK). The
CTSL2 polyclonal antibodies recognize three bands by Western blot analysis, corresponding to the three
processed forms of CTSL2 protein in cells. Protein lysates (15 mg) of dark or light keratinocytes were used
to detect CTSL2, and 2 mg of the same lysates were used to detect b-actin. The experiment was carried out
twice with four different lots of keratinocytes. Representative data are shown. (b–e) Human skin biopsies
were obtained from the Cooperative Human Tissue Network Eastern Division (Philadelphia, PA). Skin
pigment deposition levels were documented by Fontana–Mason staining. (b and c) Examples of lightly
and darkly pigmented skins are presented. (d and e) Immunohistochemistry was performed with
anti-CTSL2 antibodies using skin sections of same individuals (b and d, c and e, are each from the
same individual). Sections were counterstained with hematoxylin (Vector Labs, Burlingame, CA).
CTSL2 protein levels are higher in (d) lighter skins, and are strongly reduced in (e) darker skins.
Immunohistochemistry was repeated twice, with total of 16 skin sections, eight each from lightly and
darkly pigmented skins. Representative pictures are shown. Bar¼ 0.05 mm.
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Ashy skin is a condition that affects
many dark-skinned individuals. Ashi-
ness is described as a common physio-
logical skin condition, induced by
environmental influence, and in parti-
cular by cold and dry weather. In dry
conditions, light reflectance from dead
stratum corneum cells of dark skins
results in a dull, ashy look. Ashy skin
has seldom been studied, but is known
to be unrelated to inflammation or to
skin pathology (Uhoda et al., 2003).
The development of ashiness might
result from defects in corneodesmolysis
and desquamation (Sato et al., 1998), in
which enzymatic activities of proteases,
particularly serine- and cathepsin-like
enzymes, might be altered. Here, we
show that CTSL2 is differentially ex-
pressed in ethnic skins, with lower
levels of mRNA, protein, and enzy-
matic activity in darkly pigmented
skins. While the physiological function
of CTSL2 in human skin remains to be
explored, we hypothesize that reduced
proteolytic activity within the stratum
corneum of darker skins is involved, at
least in part, in the creation of the ‘‘ashy
skin phenotype’’. CTSL2 has been
identified as a human stratum corneum
desquamation processing-related en-
zyme (Bernard et al., 2003), further
supporting our hypothesis. This work
highlights the importance of under-
standing ethnic skin at a deeper level
than skin color. Johnson & Johnson
CPPW, a division of Johnson & Johnson
Consumer Companies Inc. approved all
described studies.
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